4-102609955-A-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_003998.4(NFKB1):​c.2228-620A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.634 in 152,094 control chromosomes in the GnomAD database, including 31,574 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.63 ( 31574 hom., cov: 32)

Consequence

NFKB1
NM_003998.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.877

Publications

22 publications found
Variant links:
Genes affected
NFKB1 (HGNC:7794): (nuclear factor kappa B subunit 1) This gene encodes a 105 kD protein which can undergo cotranslational processing by the 26S proteasome to produce a 50 kD protein. The 105 kD protein is a Rel protein-specific transcription inhibitor and the 50 kD protein is a DNA binding subunit of the NF-kappa-B (NFKB) protein complex. NFKB is a transcription regulator that is activated by various intra- and extra-cellular stimuli such as cytokines, oxidant-free radicals, ultraviolet irradiation, and bacterial or viral products. Activated NFKB translocates into the nucleus and stimulates the expression of genes involved in a wide variety of biological functions. Inappropriate activation of NFKB has been associated with a number of inflammatory diseases while persistent inhibition of NFKB leads to inappropriate immune cell development or delayed cell growth. NFKB is a critical regulator of the immediate-early response to viral infection. Alternative splicing results in multiple transcript variants encoding different isoforms, at least one of which is proteolytically processed. [provided by RefSeq, Aug 2020]
NFKB1 Gene-Disease associations (from GenCC):
  • immunodeficiency, common variable, 12
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)
  • common variable immunodeficiency
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.799 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_003998.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NFKB1
NM_003998.4
MANE Select
c.2228-620A>G
intron
N/ANP_003989.2
NFKB1
NM_001382625.1
c.2228-620A>G
intron
N/ANP_001369554.1
NFKB1
NM_001382626.1
c.2228-620A>G
intron
N/ANP_001369555.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NFKB1
ENST00000226574.9
TSL:1 MANE Select
c.2228-620A>G
intron
N/AENSP00000226574.4
NFKB1
ENST00000394820.8
TSL:1
c.2225-620A>G
intron
N/AENSP00000378297.4
NFKB1
ENST00000505458.5
TSL:1
c.2225-620A>G
intron
N/AENSP00000424790.1

Frequencies

GnomAD3 genomes
AF:
0.634
AC:
96328
AN:
151976
Hom.:
31516
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.806
Gnomad AMI
AF:
0.596
Gnomad AMR
AF:
0.624
Gnomad ASJ
AF:
0.534
Gnomad EAS
AF:
0.536
Gnomad SAS
AF:
0.525
Gnomad FIN
AF:
0.539
Gnomad MID
AF:
0.604
Gnomad NFE
AF:
0.568
Gnomad OTH
AF:
0.616
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.634
AC:
96434
AN:
152094
Hom.:
31574
Cov.:
32
AF XY:
0.632
AC XY:
46964
AN XY:
74356
show subpopulations
African (AFR)
AF:
0.806
AC:
33454
AN:
41504
American (AMR)
AF:
0.625
AC:
9550
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.534
AC:
1852
AN:
3470
East Asian (EAS)
AF:
0.537
AC:
2769
AN:
5160
South Asian (SAS)
AF:
0.525
AC:
2534
AN:
4828
European-Finnish (FIN)
AF:
0.539
AC:
5692
AN:
10560
Middle Eastern (MID)
AF:
0.599
AC:
176
AN:
294
European-Non Finnish (NFE)
AF:
0.568
AC:
38582
AN:
67974
Other (OTH)
AF:
0.609
AC:
1283
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1754
3509
5263
7018
8772
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
764
1528
2292
3056
3820
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.538
Hom.:
3495
Bravo
AF:
0.648
Asia WGS
AF:
0.564
AC:
1958
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
1.3
DANN
Benign
0.54
PhyloP100
-0.88
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3774968; hg19: chr4-103531112; API